136 related articles for article (PubMed ID: 30128692)
1. Using Huntingtin Knock-In Minipigs to Fill the Gap Between Mouse Models and Patients with Huntington's Disease.
Liu X; Peng T; Li H
Neurosci Bull; 2018 Oct; 34(5):870-872. PubMed ID: 30128692
[No Abstract] [Full Text] [Related]
2. Activity Behaviour of Minipigs Transgenic for the Huntington Gene.
Rieke L; Fels M; Schubert R; Habbel B; Matheis T; Schuldenzucker V; Kemper N; Reilmann R
J Huntingtons Dis; 2019; 8(1):23-31. PubMed ID: 30689591
[TBL] [Abstract][Full Text] [Related]
3. Minipigs as a Large-Brained Animal Model for Huntington's Disease: From Behavior and Imaging to Gene Therapy.
Reilmann R; Schuldenzucker V
Methods Mol Biol; 2018; 1780():241-266. PubMed ID: 29856023
[TBL] [Abstract][Full Text] [Related]
4. AAV5-miHTT Gene Therapy Demonstrates Broad Distribution and Strong Human Mutant Huntingtin Lowering in a Huntington's Disease Minipig Model.
Evers MM; Miniarikova J; Juhas S; Vallès A; Bohuslavova B; Juhasova J; Skalnikova HK; Vodicka P; Valekova I; Brouwers C; Blits B; Lubelski J; Kovarova H; Ellederova Z; van Deventer SJ; Petry H; Motlik J; Konstantinova P
Mol Ther; 2018 Sep; 26(9):2163-2177. PubMed ID: 30007561
[TBL] [Abstract][Full Text] [Related]
5. Vocalisation as a Viable Assessment for Phenotyping Minipigs Transgenic for the Huntington Gene?
Rieke L; Schubert R; Matheis T; Muratori LM; Motlik J; Schramke S; Fels M; Kemper N; Schuldenzucker V; Reilmann R
J Huntingtons Dis; 2018; 7(3):269-278. PubMed ID: 30103340
[TBL] [Abstract][Full Text] [Related]
6. Gradual Phenotype Development in Huntington Disease Transgenic Minipig Model at 24 Months of Age.
Vidinská D; Vochozková P; Šmatlíková P; Ardan T; Klíma J; Juhás Š; Juhásová J; Bohuslavová B; Baxa M; Valeková I; Motlík J; Ellederová Z
Neurodegener Dis; 2018; 18(2-3):107-119. PubMed ID: 29870995
[TBL] [Abstract][Full Text] [Related]
7. Mouse Models of Huntington's Disease.
Farshim PP; Bates GP
Methods Mol Biol; 2018; 1780():97-120. PubMed ID: 29856016
[TBL] [Abstract][Full Text] [Related]
8. Behavioral phenotyping of minipigs transgenic for the Huntington gene.
Schramke S; Schuldenzucker V; Schubert R; Frank F; Wirsig M; Ott S; Motlik J; Fels M; Kemper N; Hölzner E; Reilmann R
J Neurosci Methods; 2016 May; 265():34-45. PubMed ID: 26688470
[TBL] [Abstract][Full Text] [Related]
9. Deterioration of mitochondrial bioenergetics and ultrastructure impairment in skeletal muscle of a transgenic minipig model in the early stages of Huntington's disease.
Rodinova M; Krizova J; Stufkova H; Bohuslavova B; Askeland G; Dosoudilova Z; Juhas S; Juhasova J; Ellederova Z; Zeman J; Eide L; Motlik J; Hansikova H
Dis Model Mech; 2019 Jul; 12(7):. PubMed ID: 31278192
[TBL] [Abstract][Full Text] [Related]
10. Transgenic animal models for study of the pathogenesis of Huntington's disease and therapy.
Chang R; Liu X; Li S; Li XJ
Drug Des Devel Ther; 2015; 9():2179-88. PubMed ID: 25931812
[TBL] [Abstract][Full Text] [Related]
11. A new model of Huntington's disease.
Scaduto CM
Lab Anim (NY); 2016 Feb; 45(2):50. PubMed ID: 26814342
[No Abstract] [Full Text] [Related]
12. Behavioral testing of minipigs transgenic for the Huntington gene-A three-year observational study.
Schuldenzucker V; Schubert R; Muratori LM; Freisfeld F; Rieke L; Matheis T; Schramke S; Motlik J; Kemper N; Radespiel U; Reilmann R
PLoS One; 2017; 12(10):e0185970. PubMed ID: 29016656
[TBL] [Abstract][Full Text] [Related]
13. A transgenic minipig model of Huntington's Disease.
Baxa M; Hruska-Plochan M; Juhas S; Vodicka P; Pavlok A; Juhasova J; Miyanohara A; Nejime T; Klima J; Macakova M; Marsala S; Weiss A; Kubickova S; Musilova P; Vrtel R; Sontag EM; Thompson LM; Schier J; Hansikova H; Howland DS; Cattaneo E; DiFiglia M; Marsala M; Motlik J
J Huntingtons Dis; 2013; 2(1):47-68. PubMed ID: 25063429
[TBL] [Abstract][Full Text] [Related]
14. CRISPR takes on Huntington's disease.
Eisenstein M
Nature; 2018 May; 557(7707):S42-S43. PubMed ID: 29844549
[No Abstract] [Full Text] [Related]
15. Mitochondrial Metabolism in a Large-Animal Model of Huntington Disease: The Hunt for Biomarkers in the Spermatozoa of Presymptomatic Minipigs.
Krizova J; Stufkova H; Rodinova M; Macakova M; Bohuslavova B; Vidinska D; Klima J; Ellederova Z; Pavlok A; Howland DS; Zeman J; Motlik J; Hansikova H
Neurodegener Dis; 2017; 17(4-5):213-226. PubMed ID: 28633139
[TBL] [Abstract][Full Text] [Related]
16. Revelation of the IFNα, IL-10, IL-8 and IL-1β as promising biomarkers reflecting immuno-pathological mechanisms in porcine Huntington's disease model.
Valekova I; Jarkovska K; Kotrcova E; Bucci J; Ellederova Z; Juhas S; Motlik J; Gadher SJ; Kovarova H
J Neuroimmunol; 2016 Apr; 293():71-81. PubMed ID: 27049565
[TBL] [Abstract][Full Text] [Related]
17. Widespread and sustained target engagement in Huntington's disease minipigs upon intrastriatal microRNA-based gene therapy.
Vallès A; Evers MM; Stam A; Sogorb-Gonzalez M; Brouwers C; Vendrell-Tornero C; Acar-Broekmans S; Paerels L; Klima J; Bohuslavova B; Pintauro R; Fodale V; Bresciani A; Liscak R; Urgosik D; Starek Z; Crha M; Blits B; Petry H; Ellederova Z; Motlik J; van Deventer S; Konstantinova P
Sci Transl Med; 2021 Apr; 13(588):. PubMed ID: 33827977
[TBL] [Abstract][Full Text] [Related]
18. Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntington's disease.
Valencia A; Reeves PB; Sapp E; Li X; Alexander J; Kegel KB; Chase K; Aronin N; DiFiglia M
J Neurosci Res; 2010 Jan; 88(1):179-90. PubMed ID: 19642201
[TBL] [Abstract][Full Text] [Related]
19. Reply: Late onset Huntington's disease with 29 CAG repeat expansion.
Oosterloo M; Van Belzen MJ; Bijlsma EK; Roos RA
J Neurol Sci; 2016 Sep; 368():343. PubMed ID: 27538661
[No Abstract] [Full Text] [Related]
20. Huntington's disease: genetics lends a hand.
Palfi S; Jarraya B
Nature; 2008 Jun; 453(7197):863-4. PubMed ID: 18488017
[No Abstract] [Full Text] [Related]
[Next] [New Search]
